<- Go Home
Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States.
Market Cap
$510.1M
Volume
999.4K
Cash and Equivalents
$616.2M
EBITDA
-$477.3M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$176.4M
Profit Margin
80.94%
52 Week High
$75.20
52 Week Low
$5.26
Dividend
N/A
Price / Book Value
0.64
Price / Earnings
-0.75
Price / Tangible Book Value
0.71
Enterprise Value
$339.5M
Enterprise Value / EBITDA
-0.86
Operating Income
-$538.6M
Return on Equity
63.51%
Return on Assets
-19.19
Cash and Short Term Investments
$616.2M
Debt
$445.6M
Equity
$797.9M
Revenue
$218.0M
Unlevered FCF
-$195.7M
Sector
Chemicals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium